Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP226112.RAKPgCQ5KVgf5UD6QxKvhnTIhEjLB1Grv09mKsRyHGT2I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP226112.RAKPgCQ5KVgf5UD6QxKvhnTIhEjLB1Grv09mKsRyHGT2I130_assertion type Assertion NP226112.RAKPgCQ5KVgf5UD6QxKvhnTIhEjLB1Grv09mKsRyHGT2I130_head.
- NP226112.RAKPgCQ5KVgf5UD6QxKvhnTIhEjLB1Grv09mKsRyHGT2I130_assertion description "[HOXB13-to-IL17BR expression ratio is related with tumor aggressiveness and response to tamoxifen of recurrent breast cancer: a retrospective study.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP226112.RAKPgCQ5KVgf5UD6QxKvhnTIhEjLB1Grv09mKsRyHGT2I130_provenance.
- NP226112.RAKPgCQ5KVgf5UD6QxKvhnTIhEjLB1Grv09mKsRyHGT2I130_assertion evidence source_evidence_literature NP226112.RAKPgCQ5KVgf5UD6QxKvhnTIhEjLB1Grv09mKsRyHGT2I130_provenance.
- NP226112.RAKPgCQ5KVgf5UD6QxKvhnTIhEjLB1Grv09mKsRyHGT2I130_assertion SIO_000772 17308270 NP226112.RAKPgCQ5KVgf5UD6QxKvhnTIhEjLB1Grv09mKsRyHGT2I130_provenance.
- NP226112.RAKPgCQ5KVgf5UD6QxKvhnTIhEjLB1Grv09mKsRyHGT2I130_assertion wasDerivedFrom befree-20140225 NP226112.RAKPgCQ5KVgf5UD6QxKvhnTIhEjLB1Grv09mKsRyHGT2I130_provenance.
- NP226112.RAKPgCQ5KVgf5UD6QxKvhnTIhEjLB1Grv09mKsRyHGT2I130_assertion wasGeneratedBy ECO_0000203 NP226112.RAKPgCQ5KVgf5UD6QxKvhnTIhEjLB1Grv09mKsRyHGT2I130_provenance.